Seeking Alpha

On Point Advisor's  Instablog

On Point Advisor
11 Followers
1 Following
Send Message
Donald Kay Riker, Ph.D. is President & Founder, On Point Advisors, LLC [www.onpointadvisors.com], a consumer healthcare consultancy he founded in 2007 and Editor-in-Chief, OTC Product News [www.otcproductnews.com]. Dr. Riker was a fellow at New York’s prestigious Rockefeller University,... More
My company:
OTC Product News
My blog:
OTC Product News
  • P&G Reserves Right to Reinvent OTC Sleep Category 0 comments
    Aug 31, 2010 9:52 PM | about stocks: PG, SOMX
    P&G gained right-of-first refusal for the OTC rights to Silenor® in an Rx co-promotion deal with its originator, Somaxon Pharma, San Diego, CA (press release). Silenor® is a "new" Rx treatment for sleep disruption and insomnia that resurrects a well-known compound (doxepin) that first entered the US Rx market in 1969. Arguably there has been no new active ingredient introduced into the OTC sleep aid category in 30+ years.

    Read More



    Disclosure: No positions
    Themes: Silensor, Somaxon, doxepin, sleep, OTC Stocks: PG, SOMX
Back To On Point Advisor's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Full index of posts »
Latest Followers

Latest Comments


Most Commented
Posts by Themes
acetaminophen, Ackman, Acquisitions, ACT, adulterated products, Allegra, Alli, antitussives, Arthritis supplements, asthma, Banana Boat, Bayer, Ben Gay, Benadryl, Boehringer Ingelheim, brand equity, Bullfrog, celebrities, Chattem, Ciba, colds, consent decree, consumer healthcare products, Coppertone, cough, CPC, Crest, Dayquil, denture adhesives, destocking, Dexatrim, Dial, Dieting, diphenhydramine, doxepin, drugs, endorsement, Excedrin-PM, FDA, Fixodent, Flector, flu, Glaxo, H1N1, health care, healthcare, Healthcare, Henkel, Hisamitsu, ibuprofen,
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.